This webinar demonstrates how multiplex immunohistochemistry (mIHC) can be used to simultaneously investigate the expression pattern of multiple proteins, involved in immune checkpoint control, within the context of preserved tissue architecture.
Key highlights:
mIHC allows the simultaneous detection of multiple (>6) targets of interest in a species/isotype independent manner while providing ample signal amplification
Monoclonal antibodies developed and validated by CST can enable co-detection and spatial characterization of important immune checkpoint control proteins using mIHC
